Navigation Links
Gene therapy to lower blood pressure just enough

A newly developed virus that introduces a blood pressure-lowering gene into cells and enables that gene to maintain blood pressure at healthy levels for four months promises to take gene therapy for the disorder a step closer to reality, said researchers at Baylor College of Medicine in a report released online in the Proceedings of the National Academy of Sciences.

"High blood pressure is one of the leading causes of death and disability in adults worldwide," said Dr. Bert O'Malley, chair of the BCM department of molecular and cellular biology. "A therapy that could control blood pressure could have important benefits for individuals and for the health of the world's population as well."

The gene in question -- atrial natriuretic peptide or ANP -- promises to control blood pressure through a variety of effects on key areas involved in the problem of hypertension, including the relaxation of smooth muscle cells in blood vessels, increasing the vessels' diameters, and reducing the manner in which the vessels react to agents that can constrict those vessels. ANP also improves the manner in which the kidney eliminates sodium or salt from the body and inhibits other systems, such as the sympathetic nervous system, believed linked to development of high blood pressure.

"This makes ANP an attractive agent for use in treating blood pressure," said O'Malley. "However, its use is limited by the fact that it has such short-lived activity in the blood system."

Its activity is halved 30 seconds after it enters the blood stream.

Gene therapy can make cells generate more ANP. In previous studies, however, this kind of gene reduced blood pressure to dangerously low levels, said O'Malley. Obviously, a method of controlling the gene and the amount of ANP a cell makes was needed.

The special viral vector developed by O'Malley and his colleagues combines a special kind of adenovirus altered so it does not produce disease connected to
'"/>

Source:Baylor College of Medicine


Page: 1 2

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice
8. New therapy for HIV/AIDS eliminates needles and excessive toxicity
9. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
10. Gene therapy for Parkinsons disease moves forward in animals
11. Pulsating ultrasound enhances gene therapy for tumors

Post Your Comments:
(Date:11/23/2009)...ORONTO, November 23, 2009 - The time of day matter...to a new paper produced by a research team led by ...Scarborough,s vice-principal for research and coll...gy at the St. George campus. , Capitalizing on...oplar tree, the research team examined how poplar ...
(Date:11/23/2009)...mington, CT Current research suggests that a comm...e. The related report by Nichols et al, "Unique L...w Class of TLR2 Ligands Capable of Enhancing Autoi...e American Journal of Pathology . , Multiple sc...tacks the brain and spinal cord, affects nearly 1 ...
(Date:11/23/2009)...ERMORE, Calif. - By producing some of the highest ... surfaces, scientists have a deeper understanding ...his research may lead to a new treatment for kidne...ch appears in the Nov. 23 online edition of the jo...nces , explores how peptides interact with mineral...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3OMG Announces Special Event 3A Terminology Services Information Day 60441 1OMG Announces Special Event 3A Terminology Services Information Day 60441 2OMG Announces Special Event 3A Terminology Services Information Day 60441 3AARP Commends Legislature For Saving Critical Health Care Program 60438 1Beaumont Weight Control Center Now Offers MicroNutrient Testing 60435 1Beaumont Weight Control Center Now Offers MicroNutrient Testing 60435 2
...iberia,s Lake Baikal, the world,s largest and most...severe ecological disruption as a result of climat...ussian team in the May issue of BioScience. The la...nd was designated a World Heritage Site by UNESCO ...ora are found nowhere else. Perhaps the most alarm...
...LL, N.J., April 30 BIO-key International, Inc. (O...release first quarter 2009 financial results on We...conjunction with the release, BIO-key has schedule...over the Internet on Wednesday, May 6, 2009 at 10:...wscom.com/cgi-bin/prnh/20050509/BIOKEYLOGO ) , , ...
...pril 29, 2009 (BRONX, NY) Scientists at Albert E...have combined their revolutionary new drug-deliver...eat potentially deadly drug-resistant staph infect... the online version of the Journal of Investigati...ia cause the majority of superficial and invasive ...
Other Biology News:Climate change threatens Lake Baikal's unique biota 2BIO-key(R) Announces First Quarter Earnings Release and Conference Call Schedule 2New technology shows promise against resistant staph infections 2New technology shows promise against resistant staph infections 3
(Date:11/23/2009)... as origami very high-tech origami. , Researcher...echnique for fabricating three-dimensional, single... coupling photolithography and a self-folding proc..., only a few microns thick, offer mechanical benda... the same material. , "This is a completely diffe...
(Date:11/23/2009)...al carbon layer in which the carbon atoms are arra...b. Carbon nanotubes are rolled-up sheets of graphe...te. Graphene boasts some very special characterist...thermal conductor, and reconciles such conflicting...on, graphene is impermeable to gases, which makes ...
(Date:11/23/2009)...re-FirstCall/-YMBioSciencesInc.(NYSEAmex: YMI ;TSX...ntifiesandadvancesadiverseportfolioofpromisingcanc...ayreportedthatCytopia(ASX:CYT)hascommencedenrollme...-administeredJAK1/JAK2inhibitor.Thetrialisbeingcon...omergeCytopiaintoYMhasbeenpreviouslyannouncedandis...
(Date:11/23/2009)...;s Sporicidin disinfectant solution and wipes are ...s against H1N1 and Influenza A., , ...9 -- Contec Inc, the leading manufacturer of clea...idin disinfectants have been deemed by the EPA as...ing Pandemic 2009 H1N1 influenza A virus (the swin...
Breaking Biology Technology:Water droplets direct self-assembly process in thin-film materials 2Polymer with honeycomb structure 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 2YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 3YM BIOSCIENCES REPORTS FIRST PATIENT IN PHASE I/II TRIAL OF JAK1/JAK2 INHIBITOR, CYT387 ENROLLED BY CYTOPIA 4Sporicidin Brand Disinfectant Kills H1N1 in 3 Minutes 2
... Micromet, Inc.,(Nasdaq: MITI ), a biopharmaceut...ies for the treatment of cancer, inflammation and ...stian Itin, President and Chief,Executive Officer ...cial,Group,s SIGnificant Investment Options Confer...he W Hotel in New York., Dr. Itin,s presentation ...
...r Group: CNN Expose Highlights Urgent Need for ...ARBARA, Calif., Feb. 29 CNN,s recent expose on,as...g reality that the,deadly carcinogen is virtually ...stos was used heavily in Navy ships and shipyards;...ding drywalls, flooring,roofing materials, and cem...
...endle (Nasdaq: KNDL ), a,leading, global full-ser...ed that Vice President and Chief Marketing Officer...nnual Raymond James,Institutional Investors Confer...ency Grand Cypress in Orlando, March 2-5, 2008. Ke...rch 5 at 1:40 p.m. Eastern Time., (Logo: http://...
Other Biology Technology:Micromet to Present at the Susquehanna Financial Group's SIGnificant Investment Options Conference on March 4, 2008 2Calling for a Cure 2Kendle to Present at the 29th Annual Raymond James Institutional Investors Conference 2
Mouse Anti-Human QARS Monoclonal Antibody, Unconjugated, Clone 5F5 from Abnova Corporation
Mouse Anti-IFNA2 Monoclonal Antibody, Unconjugated, Clone 1F11 from Abnova Corporation
...d to coat the inner wall of tubing with DNA-coated...at enters target cells by helium discharge with th...upport cylinder, power cord, O-rings, tubing prep ... 0.1875 inch barb-to-male Luer-Lok fittings, nitro...
...s optimized blocking and wash solutions for microa...to-use wash solutions have been validated for use ...rays (Product Code S 9936). Microarray Hybridizat...ridization Wash Buffer I: 21L • Microarray P...
Biology Products: